Akèy › Gliom Difize Entrinsik Pon
Etid klinik pou Gliom Difize Entrinsik Pon ap rekrite nan Etazini
23 etid pou Gliom Difize Entrinsik Pon ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Washington, DC11 etid
- Cincinnati, OH10 etid
- Houston, TX10 etid
- Seattle, WA10 etid
- Philadelphia, PA10 etid
- Columbus, OH10 etid
- Chicago, IL9 etid
- Boston, MA9 etid
- Durham, NC9 etid
- Aurora, CO8 etid
- Miami, FL6 etid
- Ann Arbor, MI6 etid
- St. Louis, MO5 etid
- Atlanta, GA4 etid
- Birmingham, AL3 etid
- Los Angeles, CA3 etid
- New York City, NY3 etid
Pa eta
- Alabama3 etid
- Colorado8 etid
- Distrik Columbia11 etid
- Florid7 etid
- Georgia4 etid
- Illinois9 etid
- Kalifòni5 etid
- Massachusetts9 etid
- Michigan6 etid
- Missouri5 etid
- New York3 etid
- North Carolina9 etid
- Ohio12 etid
- Pennsylvania12 etid
- Texas11 etid
- Washington10 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Ap rekriteFaz 2
12 Months – 39 Years · Tout sèks · Mizajou Sep 21, 2026 · NCT06838676CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Ap rekriteFaz 1/2
12 Months – 21 Years · Tout sèks · Mizajou Sep 11, 2026 · NCT04870944Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
Ap rekriteFaz 1
36 Months · Tout sèks · Mizajou Sep 9, 2026 · NCT07076498NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
Ap rekriteFaz 1
Laj 3 a 25 · Tout sèks · Mizajou Sep 9, 2026 · NCT07664176Targeted Pediatric High-Grade Glioma Therapy
Ap rekriteEtid obsèvasyon
12 Months – 39 Years · Tout sèks · Mizajou Sep 8, 2026 · NCT05839379Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Ap rekriteFaz 1/2
Jiska laj 26 · Tout sèks · Mizajou Sep 3, 2026 · NCT06465199Study of Olutasidenib and Temozolomide in HGG
Ap rekriteFaz 2
Laj 12 a 39 · Tout sèks · Mizajou Sep 1, 2026 · NCT06161974PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Ap rekriteFaz 2
Laj 3 a 39 · Tout sèks · Mizajou Aug 24, 2026 · NCT05096481Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Ap rekriteFaz 2
Laj 1 a 26 · Tout sèks · Mizajou Aug 4, 2026 · NCT07680439Atovaquone Combined With Radiation in Children With Malignant Brain Tumors
Ap rekriteFaz 1
Laj 2 a 25 · Tout sèks · Mizajou Aug 3, 2026 · NCT06624371C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Ap rekriteFaz 1
12 Months – 25 Years · Tout sèks · Mizajou Aug 3, 2026 · NCT04099797Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Ap rekriteFaz 1/2
Laj 4 a 39 · Tout sèks · Mizajou Jul 20, 2026 · NCT05278208Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 1 a 21 · Tout sèks · Mizajou Jun 29, 2026 · NCT06333899Combination Therapy for the Treatment of Diffuse Midline Gliomas
Ap rekriteFaz 2
Laj 2 a 39 · Tout sèks · Mizajou Jun 26, 2026 · NCT05009992Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Ap rekriteFaz 2
12 Months – 39 Years · Tout sèks · Mizajou May 29, 2026 · NCT05843253Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Ap rekriteFaz 1
Laj 1 a 26 · Tout sèks · Mizajou Apr 13, 2026 · NCT04185038A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
Ap rekriteFaz 1 bonè
Jiska laj 21 · Tout sèks · Mizajou Mar 18, 2026 · NCT04655404rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
Ap rekriteFaz 1
12 Months – 18 Years · Tout sèks · Mizajou Mar 17, 2026 · NCT04943848FUS Etoposide for DMG
Ap rekriteFaz 1
Laj 4 a 21 · Tout sèks · Mizajou Jan 28, 2026 · NCT05762419Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 1 a 21 · Tout sèks · Mizajou Dec 8, 2025 · NCT05956821International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 20, 2025 · NCT03101813Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
Ap rekriteEtid obsèvasyon
Jiska laj 21 · Tout sèks · Mizajou Aug 20, 2024 · NCT01106794xPedite: A Study to Expedite DIPG and DMG Research
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Apr 30, 2024 · NCT06140719Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.